Live news related to DBV TECHNOLOGIES stock (FR0010417345): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
DBV Technologies' stock closed at €3.20 on Friday, marking a weekly decline of 11.11%. This underperformance comes in a context where the CAC 40 limit…
DBV Technologies' stock has fallen by 6.42% this Tuesday, December 23, at mid-session, trading at 3.2050 euros compared to 3.43 euros the previous day…
DBV Technologies experienced a significant rise of 30% on Wednesday, December 17, following the announcement of positive results from the phase 3 VITE…
DBV Technologies' stock closed the session on Wednesday, December 17, with a significant increase, reaching 3.68 euros from 3.07 euros the previous da…
DBV Technologies announced on Tuesday the positive results of its phase 3 VITESSE study on its Viaskin Peanut patch for children with peanut allergies…
DBV Technologies has announced promising preliminary results for the phase 3 VITESSE study, evaluating the Viaskin Peanut patch in children aged 4 to …
The biotech company's stock surpasses €3.59 this Monday morning, extending its upward trajectory that began earlier in the week. This rise is part of …
Shares of the French biotech company specializing in food allergy treatments dropped 6.81% at midday on Friday, December 12, trading at 3.21 euros com…
The stock of the French biotech company specializing in the treatment of food allergies jumped by 5.58% at midday this Thursday, December 11, trading …
